Fig. 2From: The clinical application of cancer immunotherapy based on naturally circulating dendritic cellsProduction protocols for naturally circulating dendritic cells. Schematic overview of the (a) CD1c+ myeloid dendritic cell (mDC) and (b) plasmacytoid dendritic cell (pDC) production protocols and vaccination strategy of the various clinical trialsBack to article page